Russell Investments Group
ASND icon

Russell Investments Group’s Ascendis Pharma A/S ASND Stock Holding History

Russell Investments Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
48,360
+8,094
+20% +$1.89M 0.01% 924
2026
Q1 		$9.21M Buy
40,266
+5,356
+15% +$1.2M 0.01% 986
2025
Q4 		$7.44M Sell
34,910
-6,549
-16% -$1.35M 0.01% 1084
2025
Q3 		$8.24M Buy
41,459
+12,092
+41% +$2.26M 0.01% 999
2025
Q2 		$5.07M Buy
29,367
+5,621
+24% +$916K 0.01% 1205
2025
Q1 		$3.7M Buy
23,746
+20,532
+639% +$2.93M 0.01% 1337
2024
Q4 		$442K Buy
3,214
+6
+0.2% +$789 ﹤0.01% 2310
2024
Q3 		$479K Hold
3,208
– – ﹤0.01% 2288
2024
Q2 		$438K Hold
3,208
– – ﹤0.01% 2247
2024
Q1 		$485K Hold
3,208
– – ﹤0.01% 2209
2023
Q4 		$404K Sell
3,208
-4,166
-56% -$415K ﹤0.01% 2288
2023
Q3 		$691K Sell
7,374
-40,252
-85% -$3.77M ﹤0.01% 2107
2023
Q2 		$4.25M Sell
47,626
-6,577
-12% -$572K 0.01% 1167
2023
Q1 		$5.81M Sell
54,203
-4,760
-8% -$545K 0.01% 1038
2022
Q4 		$7.2M Sell
58,963
-7,239
-11% -$840K 0.01% 915
2022
Q3 		$6.83M Buy
66,202
+16,970
+34% +$1.61M 0.02% 900
2022
Q2 		$4.58M Buy
49,232
+12,447
+34% +$1.17M 0.01% 1145
2022
Q1 		$4.32M Buy
36,785
+10,332
+39% +$1.2M 0.01% 1244
2021
Q4 		$3.56M Buy
26,453
+998
+4% +$148K 0.01% 1471
2021
Q3 		$4.06M Buy
25,455
+5,214
+26% +$714K 0.01% 1373
2021
Q2 		$2.66M Buy
+20,241
New +$2.7M ﹤0.01% 1743

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Russell Investments Group's ASND Position: Q2 2026 in Review

Russell Investments Group increased its Ascendis Pharma A/S (ASND) stake by 20% in Q2 2026, buying an estimated $1.89M and bringing the position to 48,360 shares worth $12.9M. The position accounts for 0.01% of the portfolio, ranked #924.

Russell Investments Group first reported a position in ASND in Q2 2021 and has held it in 21 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Russell Investments Group held 48,360 shares of Ascendis Pharma A/S worth $12.9M as of Q2 2026.
  • Russell Investments Group bought 8,094 Ascendis Pharma A/S shares in Q2 2026, an estimated $1.89M.
  • Ascendis Pharma A/S made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #924 holding.
  • Russell Investments Group first reported a position in Ascendis Pharma A/S in Q2 2021 and has held it in 21 quarters since.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.